Hantavirus infection in British Columbia: An atypical case history and epidemiological review

British Columbia Medical Journal

Volumn 47, Issue 5, 2005, Pages 234-240

  MacDougall, L ^a,b   Fyfe, M ^b   Bowie, William R ^c   Cooper, K ^d   McCauley, G D ^e   Morshed, M ^b  

^a Canadian Field Epidemiology Program   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Interior Health Authority of British Columbia   (United Kingdom)

^e KELOWNA GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23844501042     PISSN: 00070556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. US Centers for Disease Control and Prevention. All about hantavirus: Clinical disease manifestations. www.cdc.gov/ncidod/diseases/hanta/hps/noframes/ phys/clinical.htm (accessed 19 August 2003).
2. Young JC, Hansen GR, Graves TK, et al. The incubation period of hantavirus pulmonary syndrome. Am J Trop Med Hyg 2000;62:714-717.
3. Control of Communicable Diseases Manual, 17th ed. James Chin (ed). Washington, DC: American Public Health Association; 2000.
4. Drebot MA, Artsob H, Werker D. Hantavirus Pulmonary Syndrome in Canada, 1989-1999. Canada Communicable Disease Report. Vol 26. 15 April 2000.
5. Hantavirus Pulmonary Syndrome (HPS) Cases: The Americas through 2000. Washington, DC: PAHO; 1999.
6. Padula P, Edelstein A, Miguel SD, et al. Hantavirus pulmonary syndrome (HPS) outbreak in Argentina: Molecular evidence of person-to-person transmission of Andes virus. Virology 1998;241:323-330.
7. Childs JE, Krebs, JW, Ksiazek TG, et al. A household-based, case-control study of environmental factors associated with hantavirus pulmonary syndrome in the southwestern United States. Am J Trop Med Hyg 1995;52:393-397.
8. Jay M, Hjelle B, Davis R, et al. Occupational exposure leading to a hantavirus pulmonary syndrome in a utility company employee. Clin Infect Dis 1996;22:841-844.
9. Zeitz PS, Graber JM, Voorhees RA, et al. Assessment of occupational risk for hantavirus infection in Arizona and New Mexico. J Occup Environ Med 1997;39:463-467.
10. Castillo C, Mardones J, Villagra E. Prevalence of anti-hantavirus antibodies in health care personnel in direct contact with patients with hantavirus pulmonary syndrome in Temuco, Chile 1997-1999. Rev Med Chil 2000;128:735-739.
11. Chaparro J, Vega J, Terry W, et al. Assessment of person-to-person transmission of hantavirus pulmonary syndrome in a Chilean hospital setting. J Hosp Infect 1988;40:281-285.
12. Chapman LE, Ellis BA, Koster FT, et al. Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. Clin Infect Dis 2002;34:293-304.